Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
Abstract
Identifying the dissemination patterns and impacts of a virus of economic or health importance during a pandemic is crucial, as it informs the public on policies for containment in order to reduce the spread of the virus. In this study, we integrated genomic and travel data to investigate the emergence and spread of the B.1.1.318 and B.1.525 variants of interest in Nigeria and the wider Africa region. By integrating travel data and phylogeographic reconstructions, we find that these two variants that arose during the second wave emerged from within Africa, with the B.1.525 from Nigeria, and then spread to other parts of the world. Our results show how regional connectivity in downsampled regions like Africa can often influence virus transmissions between neighbouring countries. Our findings demonstrate the power of genomic analysis when combined with mobility and epidemiological data to identify the drivers of transmission in the region, generating actionable information for public health decision makers in the region.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by TEDs Audacious Project, including the ELMA Foundation MacKenzie Scott the Skoll Foundation and Open Philanthropy. This work was also partly supported by grants from the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov) NIH-H3Africa (https://h3africa.org) (U01HG007480 and U54HG007480) the World Bank (projects ACE-019 and ACE-IMPACT) the Rockefeller Foundation (Grant 2021 HTH) the Africa CDC through the African Society of Laboratory Medicine [ASLM] (Grant INV018978) the Wellcome Trust (Project 216619/Z/19/Z) the WARN-ID/CREID grant U01AI151812 and the Science for Africa Foundation
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The samples used in this study were de-identified from individual labs within Nigeria during routine surveillance and testing of SARS-CoV-2. The National Health Research Ethics Committee of Nigeria (NHREC) gave ethical approval for this work with approval number NHREC/01/01/2007-30/11/2021B.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are availale online at: https://github.com/acegid/SARS-CoV-2_Manucript_Supplemental_Data
https://github.com/acegid/SARS-CoV-2_Manucript_Supplemental_Data
Subject Area
- Addiction Medicine (367)
- Allergy and Immunology (688)
- Anesthesia (184)
- Cardiovascular Medicine (2740)
- Dermatology (234)
- Emergency Medicine (412)
- Epidemiology (12386)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4252)
- Geriatric Medicine (394)
- Health Economics (699)
- Health Informatics (2749)
- Health Policy (1017)
- Hematology (369)
- HIV/AIDS (878)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (451)
- Neurology (4026)
- Nursing (216)
- Nutrition (598)
- Oncology (2122)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (311)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (477)
- Pediatrics (1146)
- Primary Care Research (465)
- Public and Global Health (6644)
- Radiology and Imaging (1444)
- Respiratory Medicine (886)
- Rheumatology (420)
- Sports Medicine (351)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)